Effectiveness of tranexamic acid in reducing blood loss during caesarean section

Efficacy of tranexamic acid in reducing perioperative blood loss during caesarean section- a randomized controlled trial - Nil

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/11/060390

Enrollment

Registered

2023-11-30

Start date

Unknown

Completion date

Unknown

Last updated

2023-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O00-O9A- Pregnancy, childbirth and the puerperium

Interventions

Intervention1: 1gram of tranexamic acid in 100ml normal saline: 1gram of tranexamic acid in 100ml normal saline is given 10mins before incision of caesarean section. Patients hb preoperatively and aft

Eligibility

Inclusion criteria

Inclusion criteria: ASA 2 parturients for elective caesarean section. Singleton pregnancy.

Exclusion criteria

Exclusion criteria: Hemodynamically unstable pregnant women. Patients with history of DVT and other thromboembolic events in the past.

Design outcomes

Primary

Measure	Time frame
To assess the perioperative blood loss in caesarean sectionTimepoint: 48hr after caesarean section	—

Secondary

Measure	Time frame
Adverse drug reaction of tranexamic acidTimepoint: Perioperative, 48hours after surgery	—

Countries

India

Contacts

Public ContactAlbin Joseph

MOSC Medical college, Kolenchery

drsam_p@hotmail.com9447209010

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026